A compact, temp-stable, and easy-to-use epinephrine autoinjector
Location: United States, Massachusetts, Watertown Town
Employees: 11-50
Total raised: $39M
Founded date: 2011
Investors 7
Funding Rounds 1
| Date | Series | Amount | Investors |
| 21.01.2022 | Series B | $39M | - |
Mentions in press and media 4
| Date | Title | Description |
| 21.01.2022 | Windgap Medical Closes Over $39M Series B-1 Funding | Windgap Medical, a Watertown MA-based provider of a pharmaceutical and drug delivery platform, raised $39M in Series B-1 funding. The round was led by Taiwania Capital with participation from Shepherd Kaplan Krochuk, Molex Ventures and Cobr... |
| 25.01.2019 | Windgap Medical Receives Strategic Investment | Windgap Medical, Inc., a Watertown, Mass.-based pharmaceutical company, received a strategic investment of undisclosed amount. The round was led by Shepherd Kaplan Krochuck, with participation from Molex Ventures, a subsidiary of Koch Indus... |
| 01.06.2015 | Watch out, EpiPen: A better auto-injector for severe allergies is in the works | There are other contenders — Sanofi’s two-year-old Auvi-Q is the frontrunner — but the market’s ripe for new options for patients with allergies, CEO Chris Stepanian said. Windgap is targeting a market release by 2018, so it’s still a few y... |
| - | Watch out, EpiPen: A better auto-injector for severe allergies is in the works | Boston-area startup Windgap Medical is going right up against the ubiquitous EpiPen: It’s working on a more streamlined version of the epinephrine auto-injector. As allergies rise, so does the need for on-the-spot epinephrine treatment. Win... |